Avadel Pharmaceuticals Plc

Ownership Transactions Reported by 11 Insiders

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland

Insiders trading volume in the past year

Avadel Pharmaceuticals Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gregory J. Divis Chief Executive Officer, Director $2.31M Feb 20, 2024
Thomas S. Mchugh Chief Financial Officer $1.17M +$29K +2.55% Feb 20, 2024
Mark Anthony McCamish Director $974K -$1.09M -52.8% Jul 30, 2024
Geoffrey Michael Glass Director $856K Jul 30, 2024
Eric J. Ende Director Jul 30, 2024
Richard J. Kim Chief Commercial Officer Feb 20, 2024
Jerad G. Seurer Gen. Counsel & Corp. Secretary Apr 30, 2024
Douglas J. Williamson Chief Medical Officer Feb 14, 2022
Naseem Amin Director Jul 30, 2024
Peter J. Thornton Director Jul 30, 2024
Linda Palczuk Director Jul 30, 2024

Recent Insider Transactions by Companies or Individuals for Avadel Pharmaceuticals Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.